|Statement||editors, John L. Gueriguian, Vittorio Fattorusso, Duilio Poggiolini.|
|Contributions||Gueriguian, John L., Fattorusso, V. 1921-, Poggiolini, Duilio., Interscience Foundation.|
|LC Classifications||RS380 .B57 1988|
|The Physical Object|
|Pagination||xii, 195 p. :|
|Number of Pages||195|
|LC Control Number||88042847|
Title(s): Biotechnologically derived medical agents: the scientific basis of their regulation: proceedings of a conference sponsored and organized by Interscience, Paris, September , / editors, John L. Gueriguian, Vittorio Fattorusso, Duilio Poggiolini. Country of Publication: United States Publisher: New York, N.Y.: Raven Press, c Synthesis of Medicinal Agents from Plants. Book • This chapter is confined to those drugs that were isolated from natural resources or being derived from them, and have their medical applications as well as abuse. We have described from their historical background the chemical and biosyntheses. Herein, we have reviewed amphetamine. The book discusses a range of biotechnologically valuable bioactive compounds and secondary metabolites that have been derived from plant and microorganisms from various ecological niches. It also reviews the latest developments in the field of genomics, bioinformatics and industrial fermentation for harnessing the microbial products for commercial : Springer Singapore. This introductory text explains both the basic science and the applications of biotechnology-derived pharmaceuticals, with special emphasis on their clinical use. It serves as a complete one-stop source for undergraduate/graduate pharmacists, pharmaceutical science students, and for those in the pharmaceutical industry.
J.L. Gueriguian, V. Fattorusso, D. Poggiolini (Eds.), Biotechnologically Derived Medical Agents. The Scientific Basis of Their Regulation, Raven Press (), pp. View Record in Scopus Google Scholar. Purchase Medical Cell Biology - 3rd Edition. Print Book & E-Book. ISBN , Safety Evaluation of Biotechnologically-derived Pharmaceuticals Safety Evaluation of Pharmaceuticals and Medical Devices Safety Factor Profile Control in a Tokamak. Susan A Griffiths, Cyndy E Lumley, Non-clinical safety studies for biotechnologically-derived pharmaceuticals: conclusions from an International Workshop, Human & Experimental Toxicology, /, 17, 2, (), ().
Medical Biotechnology is written to educate premed and medical students, dental students, pharmacists, optometrists, nurses, nutritionists, genetic counselors, hospital administrators, and individuals who are stakeholders in the understanding and advancement of biotechnology and its impact on the practice of modern s: 1. Wolff S, "Automatic coding of medical vocabulary", In: Sager N, Friedman C, and Lyman MS, eds, Medical Information Processing -Computer Management of Narrative Data. . Biomaterials, Medical Devices, and Combination Products is a single-volume guide for those responsible for-or concerned with-developing and ensuring patient safety in the use and manufacture of medical book provides a clear presentation of the global regulatory requirements and challenges in evaluating the biocompatibility and clinical. Handbook of Pharmaceutical Granulation Technology: Edition 3 - Ebook written by Dilip M. Parikh. Read this book using Google Play Books app on your PC, android, iOS devices. Download for offline reading, highlight, bookmark or take notes while you read Handbook of .